Last month, a Philadelphia-based biotech company kicked off a clinical trial that pushes the envelope of what it means to be dead. Armed with ethical approval from the IRB at... read more
from L'Info Autrement's followed topics | Scoop.it http://ift.tt/1skUASO
via IFTTT
Aucun commentaire:
Enregistrer un commentaire